Standard
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib : Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? / Urbanska, Edyta Maria; Sørensen, Jens Benn; Santoni-Rugiu, Eric.
I:
Journal of Thoracic Oncology, Bind 18, Nr. 3, 2023, s. e28-e29.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Urbanska, EM
, Sørensen, JB & Santoni-Rugiu, E 2023, '
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?',
Journal of Thoracic Oncology, bind 18, nr. 3, s. e28-e29.
https://doi.org/10.1016/j.jtho.2022.11.028APA
Urbanska, E. M.
, Sørensen, J. B., & Santoni-Rugiu, E. (2023).
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? Journal of Thoracic Oncology,
18(3), e28-e29.
https://doi.org/10.1016/j.jtho.2022.11.028Vancouver
Urbanska EM
, Sørensen JB, Santoni-Rugiu E.
Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? Journal of Thoracic Oncology. 2023;18(3):e28-e29.
https://doi.org/10.1016/j.jtho.2022.11.028Author
Urbanska, Edyta Maria ; Sørensen, Jens Benn ; Santoni-Rugiu, Eric. / Efficacy of Brigatinib After Progression on Alectinib or Ceritinib : Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?. I: Journal of Thoracic Oncology. 2023 ; Bind 18, Nr. 3. s. e28-e29.
Bibtex
@article{ea87686bb53c48b5a24117aeaf1ad481,
title = "Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?",
author = "Urbanska, {Edyta Maria} and S{\o}rensen, {Jens Benn} and Eric Santoni-Rugiu",
year = "2023",
doi = "10.1016/j.jtho.2022.11.028",
language = "English",
volume = "18",
pages = "e28--e29",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier",
number = "3",
}
RIS
TY - JOUR
T1 - Efficacy of Brigatinib After Progression on Alectinib or Ceritinib
T2 - Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
AU - Urbanska, Edyta Maria
AU - Sørensen, Jens Benn
AU - Santoni-Rugiu, Eric
PY - 2023
Y1 - 2023
U2 - 10.1016/j.jtho.2022.11.028
DO - 10.1016/j.jtho.2022.11.028
M3 - Letter
C2 - 36842817
AN - SCOPUS:85148721769
VL - 18
SP - e28-e29
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
SN - 1556-0864
IS - 3
ER -
